Edition:
India

Jaguar Health Inc (JAGX.OQ)

JAGX.OQ on NASDAQ Stock Exchange Capital Market

0.14USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$0.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
670,320
52-wk High
$1.52
52-wk Low
$0.11

Select another date:

Thu, Feb 1 2018

BRIEF-Jaguar Health Files For Resale Or Other Disposition Of Up To 6.02 Mln Shares Of Voting Common Stock

* JAGUAR HEALTH INC FILES FOR RESALE OR OTHER DISPOSITION OF UP TO 6.02 MILLION SHARES OF VOTING COMMON STOCK - SEC FILING Source text: [http://bit.ly/2BJoioW] Further company coverage:

BRIEF-Jaguar Health Provides Updates Regarding Programs

* JAGUAR HEALTH PROVIDES UPDATES REGARDING COMMERCIAL, EDUCATIONAL & PRODUCT DEVELOPMENT PROGRAMS AND 2017 RESULTS FOR MYTESI SINCE MERGER (AUGUST–DECEMBER 2017) Source text for Eikon: Further company coverage:

BRIEF-Jaguar Health Says Unit Entered Amendment To Note Purchase Agreement

* JAGUAR HEALTH - ON DEC 29, 2017, UNIT ENTERED AMENDMENT TO NOTE PURCHASE AGREEMENT & NOTES WITH EACH OF PURCHASERS PARTY TO AGREEMENT DATED MARCH 1, 2017

BRIEF-Jaguar Health ‍Enters Collaboration Agreement With SEED For Equilevia​

* JAGUAR HEALTH INC - ‍ENTERED COLLABORATION AGREEMENT WITH SEED MENA BUSINESSMEN SERVICES FOR EQUILEVIA​

BRIEF-Jaguar Health enters share purchase agreement

* JAGUAR HEALTH ENTERS SHARE PURCHASE AGREEMENT FOR 2 MILLION SHARES AND COMMON STOCK PURCHASE AGREEMENT RELATING TO A 10 MILLION SHARE EQUITY LINE OFFERING WITH L2 CAPITAL, LLC

BRIEF-Jaguar Health ‍signs non-binding term sheet to issue note to Iliad Research

* Jaguar health enters non-binding agreement of terms to issue a secured convertible note to iliad research and trading, l.p. (an affiliate of chicago venture partners, l.p.), as jaguar expands commercial efforts for mytesi

BRIEF-Jaguar Health enters into letter agreement with Maxim Group LLC

* Jaguar Health - ‍on Oct 25,co entered into letter agreement with Maxim Group LLC which amends certain terms of underwriting agreement dated Sept 29​ Source text : (http://bit.ly/2y8b9cc) Further company coverage:

BRIEF-Jaguar Health files for resale or other disposition of up to 36 million shares of co

* Jaguar Health files for resale or other disposition of up to 36 million shares of co by the selling shareholders ‍​ Source text: (http://bit.ly/2gxkRxa) Further company coverage:

BRIEF-Jaguar Health prices $4.25 million public offering of common stock

* Jaguar health prices $4.25 million public offering of common stock

BRIEF-Jaguar unit Napo Pharmaceuticals files CMC supplement with FDA

* Jaguar subsidiary Napo Pharmaceuticals files CMC supplement with FDA for sample-size bottles of mytesi, Napo's FDA-approved human drug, to support upcoming national sample campaign Source text for Eikon: Further company coverage:

Select another date: